NLA Community
Groups
Blogs
Events
Slides
Documents
Photo Gallery
Videos
Polls
|
MWLA Officer and Board of Director Nominations
The Nominating Committee recommends the following slate of candidates to serve in the Officer and available at-large Board member positions.
In accordance with the Bylaws of the Midwest Lipid Association, the office of the President and Immediate Past-President are not elected. The offices of the President-Elect, the Treasurer, and the Secretary are elected. If affirmed, these MWLA members take their respective roles immediately following the MWLA Annual Business Meeting.
| 2011-2012 Midwest Lipid Association Executive Committee | Those Nominated to Serve in At-Large Direction Positions |
|
President
J. Chris Bradberry, PharmD
Omaha, NE
President-Elect
Tara L. Dall, MD
Delafield, WI
Treasurer
Alan S. Brown, MD
Naperville, IL
Secretary
Janet L. Maxson, PhD, NP-C, PA-C
Minot, ND
Immediate Past-President
Carl E. Orringer, MD
Cleveland, OH
|
Term Expiring 2013
Peter P. Toth, MD, PhD
Sterling, IL
Term Expiring 2014
Becky K. Captain, MSN
Kansas City, MO
Edgar K. Lerma, MD
Evergreen Park, IL
Kevin C. Maki, PhD
Glen Ellyn, IL
Suneet Verma, MD
Sioux Falls, SD
Kaye-Eileen Willard, MD
Racine, WI
|
See Sections 4.2 and 5.1 of the MWLA Bylaws regarding nominations from the floor.
4.2 Election of Officers
(a) The President, President-Elect, Secretary, and Treasurer are elected for a term of one (1) year, or until successors are elected, by a majority vote of the members present at the Business Meeting. Following the Nominating Committee's report, nominations for Officers may also be made from the floor of the Annual Meeting provided that a petition, signed by at least ten (10) active members in support of each nominee, has been received by the Board of Directors at least thirty (30) days prior to the Business Meeting.
(b) All Officers shall immediately assume their respective offices and the President-Elect shall automatically succeed to President at the end of the Business Meeting
5.1 Election of the Board of Directors
(a) The Board of Directors shall consist of a maximum of twenty-one (21) members including the President, President-Elect, Secretary, Treasurer, Immediate Past-President, and general Board members.
(b) Excluding the Officers, valid nominations for at large positions on the Board shall include the recommendations of the Nominating Committee and nominations from the floor of the Business Meeting, provided that a petition signed by ten (10) members in support of each floor nominee has been submitted to the Board of Directors at least thirty (30) days prior to the Annual Meeting.
Nominating Committee Members
Peter P. Toth, MD, PhD - Chair
J. Chris Bradberry, PharmD
William S. Harris, PhD
Janet L. Maxon, PhD, NP-C, PA-C
Carl E. Orringer, MD
We would like to thank the following NLA members for their service to the MWLA Board of Directors:
George S. Abela, MD, MSc, MBA, East Lansing, MI
Thomas G. Allison, PhD, MPH, Rochester, MN
Richard M. Moe, MD, PhD, Kansas City, MO
Eli M. Roth, MD, Cincinnati, OH
CoraLynn B. Trewet, PharmD, MS, BCPS, Des Moines, IA
|
|